Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy.

Samir KhandhadiaSuresh ThulasidharanNguyen Thuy Vy HoangSameh Alkhalili IbrahimYanling OuyangAndrew John Lotery

Published in: Eye (London, England) (2022)

We found overall a mean improvement in VA and structural outcomes after PDT. In the absence of randomised clinical trials this study supports the use of half dose PDT for treatment of chronic CSCR.

Keyphrases

photodynamic therapy
clinical trial
fluorescence imaging
high grade
open label
randomized controlled trial
type diabetes
drug induced
metabolic syndrome
insulin resistance